NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-211 Cr | ₹-247 Cr | ₹-363 Cr | ₹35 Cr | ₹-186 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-211 Cr |
| Mar2024 | ₹-247 Cr |
| Mar2023 | ₹-363 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹-186 Cr |
How is Cash Flow from Financing Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-211 Cr | Negative | |
| Mar2024 | ₹-247 Cr | Negative | |
| Mar2023 | ₹-363 Cr | Negative | |
| Mar2022 | ₹35 Cr | Positive | |
| Mar2021 | ₹-186 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,946.2 Cr | -1.7% | 2.6% | -31.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.7% |
2.6% |
-31.4% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses